symptomatic infection – Page 15 – Communicable Diseases Research

Experiences of early graduate medical students working in New York hospitals during the COVID-19 pandemic: a mixed methods study

Observational Study

Published on 2021-02-182022-10-04
Journal: BMC Medical Education [Category] MERS, 임상,

Clinical outcomes of initially asymptomatic patients with COVID-19: a Korean nationwide cohort study

Research Article

Published on 2021-02-132022-10-28
Journal: Annals of Medicine [Category] COVID-19,

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

의료 종사자에서 SARS-CoV-2 감염의 항체 상태 및 발생률

Article

Published on 2021-02-112022-09-11
Journal: The New England Journal of Medicine [Category] MERS, SARS, 진단, 치료법,

[키워드] 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adjusted age anti-Nucleocapsid IgG Anti-spike anti-spike antibodies anti-Spike IgG antibody antibody status assays Asymptomatic baseline baseline antibody status Chain Reaction changes in Combination coronavirus Department determine determined by Follow-up Gender Health care Health care worker incidence incidence rate investigated occurred Oxford participated PCR PCR-positive polymerase chain polymerase chain reaction positive positive PCR test presence of antibody primary analysis rate ratio rate ratios reduced risk Reinfection respiratory risk SARS-CoV-2 SARS-COV-2 infection Seroconversion seronegative seropositive severe acute respiratory syndrome Coronavirus status subsequent symptomatic symptomatic infection symptomatic infections test results tested United Kingdom university was determined was used worker
[DOI] 10.1056/NEJMoa2034545 PMC 바로가기 [Article Type] Article

Who should be prioritized for COVID-19 vaccination in China? A descriptive study

Research Article

Published on 2021-02-102022-10-28
Journal: BMC Medicine [Category] COVID-19, MERS,

[키워드] Administered Admissions Adults Analysis assist available data children China Chinese Community country Coverage COVID-19 vaccination COVID-19 vaccines Critical care deaths dose early phase Essential essential worker group groups health condition healthcare hospitalizations individual influenza pandemic information maintain National Novel coronavirus disease 2019 Older outcomes pandemic per day populations pregnant women reduce Result risk scaled up severe COVID-19 stages supplementary material supply shortage symptomatic infection target population to define Transmission vaccinate vaccination vaccination schedule Vaccine virus transmission
[DOI] 10.1186/s12916-021-01923-8 PMC 바로가기 [Article Type] Research Article

Rapid community point-of-care testing for COVID-19 (RAPTOR-C19): protocol for a platform diagnostic study

Protocol

Published on 2021-02-082022-10-31
Journal: Diagnostic and Prognostic Research [Category] COVID-19,

[키워드] 95% confidence interval Accuracy antibody test results Antibody testing asked baseline blood sample calculated Care chain children clinical care Community community testing contributing to COVID-19 death demographics diagnostic diagnostic tests Effects Electronic health record eligible estimates evaluated feasible Health hospitalisation household contacts household transmission Impact individual Infection ISRCTN Laboratory Negative predictive value outcome outcomes participant Patient patient reported performed PHE platform POCT point-of-care point-of-care test point-of-care tests positive Prevalence primary care protocol public health Public Health England Rapid reaction recruited reducing reference standard RT-PCR SARS-CoV-2 antibody testing SARS-CoV2 SARS-CoV2 infection specificity supplementary material Surveillance Swab symptomatic infection Symptoms Testing transcriptase Transmission dynamics
[DOI] 10.1186/s41512-021-00093-8 PMC 바로가기 [Article Type] Protocol

Clinical Profile and Treatment of COVID-19 Patients: Experiences from an Ethiopian Treatment Center

Observational Study

Published on 2021-02-012022-10-04
Journal: The American Journal of Tropical Medicine and Hygi [Category] MERS, SARS, 임상,

Epidemiologic trends and characteristics of SARS-CoV-2 infections among children in the United States

미국 어린이의 SARS-CoV-2 감염 역학 동향 및 특성

Review

Published on 2021-02-012022-09-11
Journal: Current opinion in pediatrics [Category] 치료기술,

[키워드] Active surveillance acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition age Asymptomatic Characteristics children clinical feature Clinical features clinical manifestation clinical manifestations Complication complications contribute coronavirus death epidemiological Frequency highest Hospitalization illnesses incidence Infant Infants Infection less majority Mild nonspecific Older pandemic pediatric recent renal reported Research respiratory respiratory distress SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 pandemic severe acute respiratory syndrome Coronavirus severe disease Severe respiratory distress Symptom symptomatic infection the SARS-CoV-2 the United State The United States United States
[DOI] 10.1097/MOP.0000000000000971 PMC 바로가기 [Article Type] Review

Forecasting hospital demand in metropolitan areas during the current COVID-19 pandemic and estimates of lockdown-induced 2nd waves

Research Article

Published on 2021-01-222022-10-28
Journal: PLoS ONE [Category] COVID-19,

[키워드] applied Asymptomatic Bayesian approach breakpoint condition confirmed case Contact COVID-19 pandemic deaths effective estimate feature Forecasting hospital increase in initial Intervention lockdown predict Probability symptomatic infection
[DOI] 10.1371/journal.pone.0245669 PMC 바로가기 [Article Type] Research Article

BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial

COVID-19에 대한 타고난 면역 반응을 개선하기 위해 브라질에서 의료 종사자의 BCG 재접종: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2020-10-262022-08-13
Journal: Trials [Category] MERS, SARS, 임상,

[키워드] accompany activate acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Admission Antibiotics antiviral immune response approved assigned Autoimmune Autoimmune diseases Bacillus BCG BCG revaccination BCG vaccination bcg vaccine blinded Blinding block blocks both groups Brazil Breastfeeding carried CFU Characteristics Chemotherapy childhood city clinical trial Committee Comorbidities Comorbidity confirmation Contact contact with control group Coronavirus-2 COVID-19 COVID-19 patient COVID-19 severity COVID-19 symptoms COVID-19 test cross-protection determined by diagnosed direct contact disease disease severity Diseases dissemination dose doses Effectiveness element elicited eligibility criteria Fever health worker health workers healthcare providers HIV hospital Hypothesis ICU identification number IgG and IgM IgM and IgG IgM test immunosuppressive IMPROVE in both group incidence incidence of COVID-19 Inclusion inclusion criteria India induce Infection infections information innate immune response investigator Laboratory lateral flow less macrophages medication meet memory monocyte Monocytes Mortality naso-oropharyngeal swab neutrophil Neutrophils NK NK cell number Nurses objective Open-label outcome outcomes pandemic parallel-group participant physiotherapists platform presenting Prevent Primary outcome Primary outcomes professional protocol randomisation randomised randomised controlled trial randomization Randomized receive recruit recruitment reduce Registered registration number researcher researchers respiratory revaccination right arm RT-PCR Sample size SARS-CoV-2 scar sealed Secondary objective Secondary objectives secondary outcome severe acute respiratory syndrome Coronavirus severity solid tumour specimen statistical analyses status steroid Study protocol Symptom symptomatic infection the disease the vaccine Trial Trial registration Tuberculosis two groups vaccination Vaccine virus virus infection virus infections was performed website WHO
[DOI] 10.1186/s13063-020-04822-0 PMC 바로가기 [Article Type] Letter

Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity

Review

Published on 2020-10-222022-10-31
Journal: Human Genomics [Category] COVID-19, MERS, SARS,

[키워드] accumulate acute respiratory syndrome Allelic variation assist association Asymptomatic binding Biomedical research candidate gene caused Cell changed Characteristics children China clinical disease clinical manifestation Clinical outcome component contribute coronavirus coronavirus disease COVID-19 COVID-19 disease severity COVID-19 severity death determinant disease course disease severity effective vaccine effort example explain Factor Genetic genetic determinant Genetic predisposition Genetic variant genetics Genotype help high risk host genetics Human immune response immunization include individual infect infected case Infection initial knowledge male mechanism morbidity and mortality Novel coronavirus observation Older pandemic Patient Polymorphisms populations reported Research Respiratory failure resulting risk Safe SARS-CoV-2 SARS-COV-2 infection severe pneumonia severity severity of COVID-19 Stage Stratification surface receptor susceptibility symptomatic infection synchronization TLR7 variant virus Wuhan X chromosome
[DOI] 10.1186/s40246-020-00290-4 PMC 바로가기 [Article Type] Review